Correlation Between Sprint Bioscience and Devyser Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Devyser Diagnostics AB, you can compare the effects of market volatilities on Sprint Bioscience and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Devyser Diagnostics.

Diversification Opportunities for Sprint Bioscience and Devyser Diagnostics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sprint and Devyser is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Devyser Diagnostics go up and down completely randomly.

Pair Corralation between Sprint Bioscience and Devyser Diagnostics

If you would invest  70.00  in Sprint Bioscience AB on October 25, 2024 and sell it today you would earn a total of  99.00  from holding Sprint Bioscience AB or generate 141.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Sprint Bioscience AB  vs.  Devyser Diagnostics AB

 Performance 
       Timeline  
Sprint Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sprint Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Devyser Diagnostics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Devyser Diagnostics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Sprint Bioscience and Devyser Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sprint Bioscience and Devyser Diagnostics

The main advantage of trading using opposite Sprint Bioscience and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.
The idea behind Sprint Bioscience AB and Devyser Diagnostics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes